Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiphospholipid syndrome].

Z Fojtík1

  • 1Interní hematoonkologická klinika Lékarské fakulty MU a FN Brno. zfojtik@fnbrno.cz

Vnitrni Lekarstvi
|September 14, 2006
PubMed
Summary
This summary is machine-generated.

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by blood clots and pregnancy complications. Diagnosis relies on specific antibodies like lupus anticoagulant (LA) and anticardiolipin (aCL), but further research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

PET/CT in giant cell arteritis: High <sup>18</sup>F-FDG uptake in the temporal, occipital and vertebral arteries.

Revista espanola de medicina nuclear e imagen molecular·2016
Same author

[The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis].

Vnitrni lekarstvi·2012
Same author

[Schnitzler syndrome: diagnostics and treatment].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2011
Same author

[Schnitzler syndrome: case report, the experience with glucocorticoid and anakinra (Kineret) therapies and monitoring of systemic cytokine response].

Vnitrni lekarstvi·2011
Same author

[The presence of dry eye syndrome and corneal complications in patients with rheumatoid arthritis and its association with -174 gene polymorphism for interleukin 6].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2008
Same journal

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023
Same journal

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023
Same journal

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023
Same journal

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023
Same journal

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023
Same journal

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023
See all related articles

Area of Science:

  • Autoimmune disorders
  • Hematology
  • Immunology

Context:

  • Antiphospholipid syndrome (APS) is defined by clinical and laboratory findings.
  • It can be a primary condition or secondary to connective tissue diseases.
  • APS is the most common acquired thrombophilia.

Purpose:

  • To define Antiphospholipid Syndrome (APS).
  • To associate clinical and laboratory manifestations with patient history.
  • To identify diagnostic criteria for APS.

Summary:

  • Clinical signs include recurrent thrombosis and fetal losses.
  • Laboratory criteria involve lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies.
  • Antiphospholipid antibodies (aPL) affect coagulation pathways, leading to thrombophilia.

Related Experiment Videos

Impact:

  • Understanding APS requires multidisciplinary collaboration.
  • Further research is needed to fully establish clinical signs and antibody evaluation.
  • Clarifying APS characteristics will aid in diagnosis and management.